Status:

UNKNOWN

High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia

Lead Sponsor:

Hadassah Medical Organization

Collaborating Sponsors:

Herzog Hospital

Conditions:

Schizophrenia

Eligibility:

All Genders

18-30 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to compare efficacy and safety of add-on treatment with a moderately high dose of D-serine, an NMDA-glycine site agonist, in young, recent onset schizophrenia patients who...

Detailed Description

Background: Recent advances in understanding the neurobiology underlying schizophrenia have underscored a pivotal role for a specific receptor for the neurotransmitter glutamate, the NMDA receptor, wh...

Eligibility Criteria

Inclusion

  • Age 18-30
  • Diagnosis of schizophrenia/schizoaffective disorder
  • Recent onset (up to five years since onset of positive symptoms)
  • Stable dose antipsychotic treatment for at least 4 weeks
  • Baseline PANSS total score of at least 70
  • Baseline PANSS negative subscale score of at least 20
  • Clinically stable (stable CGI score for two consecutive weeks)

Exclusion

  • Criteria for other DSM-IV Axis I diagnoses are met
  • Lifetime history of alcohol or substance dependence
  • Alcohol or substance abuse within the past year
  • Judged clinically to be at suicidal or homicidal risk
  • Female patients who are pregnant or lactating.
  • Patients with known intolerance to D-serine treatment
  • Patients treated with ECT within 12 weeks prior to study entry
  • Patients treated with TMS within 4 weeks prior to study entry
  • Patients suffering from an unstable and/or untreated medical disorder
  • Patients suffering from renal or hepatic dysfunction

Key Trial Info

Start Date :

November 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2014

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT01459029

Start Date

November 1 2011

End Date

October 1 2014

Last Update

October 25 2011

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Ezrath Nashim - Herzog Memorial Hospital & Community Clinics

Jerusalem, Israel

2

Hadassah Medical Organization

Jerusalem, Israel

High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia | DecenTrialz